The
ACE INTERNATIONAL PARTNERSHIP PROGRAM is for experienced and well-established editors living and working outside of the U.S., who are members of an editing organization, recognized by ACE, in their own countries.
BENEFITS
ACE International Partners become part of ACE’s network of film editing professionals. They attend ACE gatherings, receive discounts on ACE events around the world (including US events), and receive a complimentary subscription to CinemaEditor Magazine.
They are also invited to vote in the final round of the Feature Film categories of the Eddie Awards with their names listed in a special section of ACE’s Membership Roster as the second most important membership category.
Ford schnürt weiteres Hilfspaket
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Investegate |Doric Nimrod Air Two Announcements | Doric Nimrod Air Two: Holding(s) in Company
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
(0)
The DTRA Chem Bio Technologies, Vaccines and Therapeutics Division forms industry partnership with Evrys Bio to accelerate treatment for alphavirus, arenavirus and filovirus infections
DOYLESTOWN, Pa., July 13, 2021 (GLOBE NEWSWIRE) Evrys Bio, a biotech company developing Next Gen Antivirals, was awarded a $34.3 million contract from the Department of Defense (DOD) to develop a drug, simultaneously effective against multiple high-risk viral agents. The proposed drug intends to improve disease survival after exposure to one or more viruses from three families: alphaviruses, arenaviruses and filoviruses. Evrys Bio s broad-spectrum antiviral technology is based on the discovery that certain human proteins, called sirtuins, normally defend the human (host) cell from being invaded by pathogens. The novel drug will target the human SIRT-2 protein.